APO Research
Talk to an analyst

APO RESEARCH · REPORT

GLP-1 Weight Loss Injection

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global GLP-1 Weight Loss Injection Market Outlook and Growth Opportunities 2026

26 December 2025190 pages

Choose your research edition.

Industry ResearchGLP-1 Weight Loss Injection Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal GLP-1 Weight Loss Injection Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal GLP-1 Weight Loss Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal GLP-1 Weight Loss Injection Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal GLP-1 Weight Loss Injection Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global GLP-1 Weight Loss Injection market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for GLP-1 Weight Loss Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for GLP-1 Weight Loss Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for GLP-1 Weight Loss Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the GLP-1 Weight Loss Injection market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the GLP-1 Weight Loss Injection market include Novo Nordisk, Imeik, Borui Pharmaceuticals, Gan & Lee Pharmaceuticals, Hansoh Pharmaceuticals, Hengrui Medicine, Huadong Medicine, Eli Lilly and Shanghai Benemae Biopharmaceuticals Co., Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global GLP-1 Weight Loss Injection market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of GLP-1 Weight Loss Injection and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents GLP-1 Weight Loss Injection sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the GLP-1 Weight Loss Injection market size, projected growth trends, production technologies, key applications, and end-use industries.

GLP-1 Weight Loss Injection Segment by Company

Novo Nordisk

Imeik

Borui Pharmaceuticals

Gan & Lee Pharmaceuticals

Hansoh Pharmaceuticals

Hengrui Medicine

Huadong Medicine

Eli Lilly

Shanghai Benemae Biopharmaceuticals Co., Ltd.

CSPC Pharmaceutical Group

Sihuan Pharmaceuticals

Wanbang Biopharma

Innovent Biologics

GLP-1 Weight Loss Injection Segment by Type

Tirzepatide

Semaglutide

Liraglutide

Benaglutide

Others

GLP-1 Weight Loss Injection Segment by Application

Hospital

Clinic

Others

GLP-1 Weight Loss Injection Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global GLP-1 Weight Loss Injection status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions GLP-1 Weight Loss Injection market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify GLP-1 Weight Loss Injection significant trends, drivers, influence factors in global and regions.

6. To analyze GLP-1 Weight Loss Injection competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global GLP-1 Weight Loss Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of GLP-1 Weight Loss Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of GLP-1 Weight Loss Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the GLP-1 Weight Loss Injection market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global GLP-1 Weight Loss Injection industry.

Chapter 3: Detailed analysis of GLP-1 Weight Loss Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of GLP-1 Weight Loss Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of GLP-1 Weight Loss Injection in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. GLP-1 Weight Loss Injection Industry Trends Table 2. GLP-1 Weight Loss Injection Industry Drivers Table 3. GLP-1 Weight Loss Injection Industry Opportunities and Challenges Table 4. GLP-1 Weight Loss Injection Industry Restraints Table 5. Global GLP-1 Weight Loss Injection Revenue by Company (US$ Million) & (2021-2026) Table 6. Global GLP-1 Weight Loss Injection Revenue Share by Company (2021-2026) Table 7. Global GLP-1 Weight Loss Injection Sales Volume by Company (K Units) & (2021-2026) Table 8. Global GLP-1 Weight Loss Injection Sales Volume Share by Company (2021-2026) Table 9. Global GLP-1 Weight Loss Injection Average Price (US$/Unit) of Company (2021-2026) Table 10. Global GLP-1 Weight Loss Injection Company Ranking, (2024-2026) & (USD Million) Table 11. Global GLP-1 Weight Loss Injection Key Company Manufacturing Base & Headquarters Table 12. Global GLP-1 Weight Loss Injection Company, Product Type & Application Table 13. Global GLP-1 Weight Loss Injection Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global GLP-1 Weight Loss Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Tirzepatide Table 18. Significant Companies of Semaglutide Table 19. Significant Companies of Liraglutide Table 20. Significant Companies of Benaglutide Table 21. Significant Companies of Others Table 22. Global GLP-1 Weight Loss Injection Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 23. Global GLP-1 Weight Loss Injection Sales Volume by Type (2021-2026) & (K Units) Table 24. Global GLP-1 Weight Loss Injection Sales Volume by Type (2027-2032) & (K Units) Table 25. Global GLP-1 Weight Loss Injection Sales Volume Share by Type (2021-2026) Table 26. Global GLP-1 Weight Loss Injection Sales Volume Share by Type (2027-2032) Table 27. Global GLP-1 Weight Loss Injection Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global GLP-1 Weight Loss Injection Sales Value by Type (2021-2026) & (US$ Million) Table 29. Global GLP-1 Weight Loss Injection Sales Value by Type (2027-2032) & (US$ Million) Table 30. Global GLP-1 Weight Loss Injection Sales Value Share by Type (2021-2026) Table 31. Global GLP-1 Weight Loss Injection Sales Value Share by Type (2027-2032) Table 32. Significant Companies of Hospital Table 33. Significant Companies of Clinic Table 34. Significant Companies of Others Table 35. Global GLP-1 Weight Loss Injection Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 36. Global GLP-1 Weight Loss Injection Sales Volume by Application (2021-2026) & (K Units) Table 37. Global GLP-1 Weight Loss Injection Sales Volume by Application (2027-2032) & (K Units) Table 38. Global GLP-1 Weight Loss Injection Sales Volume Share by Application (2021-2026) Table 39. Global GLP-1 Weight Loss Injection Sales Volume Share by Application (2027-2032) Table 40. Global GLP-1 Weight Loss Injection Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 41. Global GLP-1 Weight Loss Injection Sales Value by Application (2021-2026) & (US$ Million) Table 42. Global GLP-1 Weight Loss Injection Sales Value by Application (2027-2032) & (US$ Million) Table 43. Global GLP-1 Weight Loss Injection Sales Value Share by Application (2021-2026) Table 44. Global GLP-1 Weight Loss Injection Sales Value Share by Application (2027-2032) Table 45. Global GLP-1 Weight Loss Injection Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 46. Global GLP-1 Weight Loss Injection Sales by Region (2021-2026) & (K Units) Table 47. Global GLP-1 Weight Loss Injection Sales Market Share by Region (2021-2026) Table 48. Global GLP-1 Weight Loss Injection Sales by Region (2027-2032) & (K Units) Table 49. Global GLP-1 Weight Loss Injection Sales Market Share by Region (2027-2032) Table 50. Global GLP-1 Weight Loss Injection Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 51. Global GLP-1 Weight Loss Injection Sales Value by Region (2021-2026) & (US$ Million) Table 52. Global GLP-1 Weight Loss Injection Sales Value Share by Region (2021-2026) Table 53. Global GLP-1 Weight Loss Injection Sales Value by Region (2027-2032) & (US$ Million) Table 54. Global GLP-1 Weight Loss Injection Sales Value Share by Region (2027-2032) Table 55. Global GLP-1 Weight Loss Injection Market Average Price (US$/Unit) by Region (2021-2026) Table 56. Global GLP-1 Weight Loss Injection Market Average Price (US$/Unit) by Region (2027-2032) Table 57. Global GLP-1 Weight Loss Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 58. Global GLP-1 Weight Loss Injection Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global GLP-1 Weight Loss Injection Sales by Country (2021-2026) & (K Units) Table 60. Global GLP-1 Weight Loss Injection Sales Market Share by Country (2021-2026) Table 61. Global GLP-1 Weight Loss Injection Sales by Country (2027-2032) & (K Units) Table 62. Global GLP-1 Weight Loss Injection Sales Market Share by Country (2027-2032) Table 63. Global GLP-1 Weight Loss Injection Sales Value by Country (2021-2026) & (US$ Million) Table 64. Global GLP-1 Weight Loss Injection Sales Value Market Share by Country (2021-2026) Table 65. Global GLP-1 Weight Loss Injection Sales Value by Country (2027-2032) & (US$ Million) Table 66. Global GLP-1 Weight Loss Injection Sales Value Market Share by Country (2027-2032) Table 67. Novo Nordisk Company Information Table 68. Novo Nordisk Business Overview Table 69. Novo Nordisk GLP-1 Weight Loss Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 70. Novo Nordisk GLP-1 Weight Loss Injection Product Portfolio Table 71. Novo Nordisk Recent Development Table 72. Imeik Company Information Table 73. Imeik Business Overview Table 74. Imeik GLP-1 Weight Loss Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Imeik GLP-1 Weight Loss Injection Product Portfolio Table 76. Imeik Recent Development Table 77. Borui Pharmaceuticals Company Information Table 78. Borui Pharmaceuticals Business Overview Table 79. Borui Pharmaceuticals GLP-1 Weight Loss Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Borui Pharmaceuticals GLP-1 Weight Loss Injection Product Portfolio Table 81. Borui Pharmaceuticals Recent Development Table 82. Gan & Lee Pharmaceuticals Company Information Table 83. Gan & Lee Pharmaceuticals Business Overview Table 84. Gan & Lee Pharmaceuticals GLP-1 Weight Loss Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Gan & Lee Pharmaceuticals GLP-1 Weight Loss Injection Product Portfolio Table 86. Gan & Lee Pharmaceuticals Recent Development Table 87. Hansoh Pharmaceuticals Company Information Table 88. Hansoh Pharmaceuticals Business Overview Table 89. Hansoh Pharmaceuticals GLP-1 Weight Loss Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Hansoh Pharmaceuticals GLP-1 Weight Loss Injection Product Portfolio Table 91. Hansoh Pharmaceuticals Recent Development Table 92. Hengrui Medicine Company Information Table 93. Hengrui Medicine Business Overview Table 94. Hengrui Medicine GLP-1 Weight Loss Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Hengrui Medicine GLP-1 Weight Loss Injection Product Portfolio Table 96. Hengrui Medicine Recent Development Table 97. Huadong Medicine Company Information Table 98. Huadong Medicine Business Overview Table 99. Huadong Medicine GLP-1 Weight Loss Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Huadong Medicine GLP-1 Weight Loss Injection Product Portfolio Table 101. Huadong Medicine Recent Development Table 102. Eli Lilly Company Information Table 103. Eli Lilly Business Overview Table 104. Eli Lilly GLP-1 Weight Loss Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Eli Lilly GLP-1 Weight Loss Injection Product Portfolio Table 106. Eli Lilly Recent Development Table 107. Shanghai Benemae Biopharmaceuticals Co., Ltd. Company Information Table 108. Shanghai Benemae Biopharmaceuticals Co., Ltd. Business Overview Table 109. Shanghai Benemae Biopharmaceuticals Co., Ltd. GLP-1 Weight Loss Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Shanghai Benemae Biopharmaceuticals Co., Ltd. GLP-1 Weight Loss Injection Product Portfolio Table 111. Shanghai Benemae Biopharmaceuticals Co., Ltd. Recent Development Table 112. CSPC Pharmaceutical Group Company Information Table 113. CSPC Pharmaceutical Group Business Overview Table 114. CSPC Pharmaceutical Group GLP-1 Weight Loss Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. CSPC Pharmaceutical Group GLP-1 Weight Loss Injection Product Portfolio Table 116. CSPC Pharmaceutical Group Recent Development Table 117. Sihuan Pharmaceuticals Company Information Table 118. Sihuan Pharmaceuticals Business Overview Table 119. Sihuan Pharmaceuticals GLP-1 Weight Loss Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 120. Sihuan Pharmaceuticals GLP-1 Weight Loss Injection Product Portfolio Table 121. Sihuan Pharmaceuticals Recent Development Table 122. Wanbang Biopharma Company Information Table 123. Wanbang Biopharma Business Overview Table 124. Wanbang Biopharma GLP-1 Weight Loss Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 125. Wanbang Biopharma GLP-1 Weight Loss Injection Product Portfolio Table 126. Wanbang Biopharma Recent Development Table 127. Innovent Biologics Company Information Table 128. Innovent Biologics Business Overview Table 129. Innovent Biologics GLP-1 Weight Loss Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 130. Innovent Biologics GLP-1 Weight Loss Injection Product Portfolio Table 131. Innovent Biologics Recent Development Table 132. Key Raw Materials Table 133. Raw Materials Key Suppliers Table 134. GLP-1 Weight Loss Injection Distributors List Table 135. GLP-1 Weight Loss Injection Customers List Table 136. Research Programs/Design for This Report Table 137. Authors List of This Report Table 138. Secondary Sources Table 139. Primary Sources List of Figures Figure 1. GLP-1 Weight Loss Injection Product Image Figure 2. Global GLP-1 Weight Loss Injection Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global GLP-1 Weight Loss Injection Sales Value (2021-2032) & (US$ Million) Figure 4. Global GLP-1 Weight Loss Injection Sales (2021-2032) & (K Units) Figure 5. Global GLP-1 Weight Loss Injection Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global GLP-1 Weight Loss Injection Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Tirzepatide Image Figure 10. Semaglutide Image Figure 11. Liraglutide Image Figure 12. Benaglutide Image Figure 13. Others Image Figure 14. Global GLP-1 Weight Loss Injection Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 15. Global GLP-1 Weight Loss Injection Sales Volume Share 2021 VS 2025 VS 2032 Figure 16. Global GLP-1 Weight Loss Injection Sales Volume Share by Type (2021-2032) Figure 17. Global GLP-1 Weight Loss Injection Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global GLP-1 Weight Loss Injection Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global GLP-1 Weight Loss Injection Sales Value Share by Type (2021-2032) Figure 20. Hospital Image Figure 21. Clinic Image Figure 22. Others Image Figure 23. Global GLP-1 Weight Loss Injection Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 24. Global GLP-1 Weight Loss Injection Sales Volume Share 2021 VS 2025 VS 2032 Figure 25. Global GLP-1 Weight Loss Injection Sales Volume Share by Application (2021-2032) Figure 26. Global GLP-1 Weight Loss Injection Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global GLP-1 Weight Loss Injection Sales Value Share 2021 VS 2025 VS 2032 Figure 28. Global GLP-1 Weight Loss Injection Sales Value Share by Application (2021-2032) Figure 29. Global GLP-1 Weight Loss Injection Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 30. Global GLP-1 Weight Loss Injection Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 31. Global GLP-1 Weight Loss Injection Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 32. Global GLP-1 Weight Loss Injection Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 33. North America GLP-1 Weight Loss Injection Sales Value (2021-2032) & (US$ Million) Figure 34. North America GLP-1 Weight Loss Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Europe GLP-1 Weight Loss Injection Sales Value (2021-2032) & (US$ Million) Figure 36. Europe GLP-1 Weight Loss Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Asia-Pacific GLP-1 Weight Loss Injection Sales Value (2021-2032) & (US$ Million) Figure 38. Asia-Pacific GLP-1 Weight Loss Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 39. South America GLP-1 Weight Loss Injection Sales Value (2021-2032) & (US$ Million) Figure 40. South America GLP-1 Weight Loss Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 41. Middle East & Africa GLP-1 Weight Loss Injection Sales Value (2021-2032) & (US$ Million) Figure 42. Middle East & Africa GLP-1 Weight Loss Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 43. USA GLP-1 Weight Loss Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. USA GLP-1 Weight Loss Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. USA GLP-1 Weight Loss Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Canada GLP-1 Weight Loss Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Canada GLP-1 Weight Loss Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Canada GLP-1 Weight Loss Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Mexico GLP-1 Weight Loss Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Mexico GLP-1 Weight Loss Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Mexico GLP-1 Weight Loss Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Germany GLP-1 Weight Loss Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Germany GLP-1 Weight Loss Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Germany GLP-1 Weight Loss Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. France GLP-1 Weight Loss Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. France GLP-1 Weight Loss Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. France GLP-1 Weight Loss Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. U.K. GLP-1 Weight Loss Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. U.K. GLP-1 Weight Loss Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. U.K. GLP-1 Weight Loss Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Italy GLP-1 Weight Loss Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Italy GLP-1 Weight Loss Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Italy GLP-1 Weight Loss Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Spain GLP-1 Weight Loss Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Spain GLP-1 Weight Loss Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Spain GLP-1 Weight Loss Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Russia GLP-1 Weight Loss Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Russia GLP-1 Weight Loss Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Russia GLP-1 Weight Loss Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Netherlands GLP-1 Weight Loss Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Netherlands GLP-1 Weight Loss Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Netherlands GLP-1 Weight Loss Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. Nordic Countries GLP-1 Weight Loss Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. Nordic Countries GLP-1 Weight Loss Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. Nordic Countries GLP-1 Weight Loss Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. China GLP-1 Weight Loss Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. China GLP-1 Weight Loss Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. China GLP-1 Weight Loss Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Japan GLP-1 Weight Loss Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Japan GLP-1 Weight Loss Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Japan GLP-1 Weight Loss Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. South Korea GLP-1 Weight Loss Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. South Korea GLP-1 Weight Loss Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. South Korea GLP-1 Weight Loss Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. India GLP-1 Weight Loss Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. India GLP-1 Weight Loss Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. India GLP-1 Weight Loss Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Australia GLP-1 Weight Loss Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Australia GLP-1 Weight Loss Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Australia GLP-1 Weight Loss Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Southeast Asia GLP-1 Weight Loss Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Southeast Asia GLP-1 Weight Loss Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Southeast Asia GLP-1 Weight Loss Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Brazil GLP-1 Weight Loss Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Brazil GLP-1 Weight Loss Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Brazil GLP-1 Weight Loss Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Argentina GLP-1 Weight Loss Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Argentina GLP-1 Weight Loss Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Argentina GLP-1 Weight Loss Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Chile GLP-1 Weight Loss Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Chile GLP-1 Weight Loss Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Chile GLP-1 Weight Loss Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Colombia GLP-1 Weight Loss Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Colombia GLP-1 Weight Loss Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Colombia GLP-1 Weight Loss Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Peru GLP-1 Weight Loss Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Peru GLP-1 Weight Loss Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Peru GLP-1 Weight Loss Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Saudi Arabia GLP-1 Weight Loss Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Saudi Arabia GLP-1 Weight Loss Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Saudi Arabia GLP-1 Weight Loss Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Israel GLP-1 Weight Loss Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Israel Arabia GLP-1 Weight Loss Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Israel Arabia GLP-1 Weight Loss Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. UAE GLP-1 Weight Loss Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. UAE GLP-1 Weight Loss Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. UAE GLP-1 Weight Loss Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Turkey GLP-1 Weight Loss Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Turkey GLP-1 Weight Loss Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Turkey GLP-1 Weight Loss Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Iran GLP-1 Weight Loss Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Iran GLP-1 Weight Loss Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Iran GLP-1 Weight Loss Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Egypt GLP-1 Weight Loss Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 125. Egypt GLP-1 Weight Loss Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 126. Egypt GLP-1 Weight Loss Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 127. GLP-1 Weight Loss Injection Value Chain Figure 128. Manufacturing Cost Structure Figure 129. GLP-1 Weight Loss Injection Sales Mode & Process Figure 130. Direct Comparison with Distribution Share Figure 131. Distributors Profiles Figure 132. Years Considered Figure 133. Research Process Figure 134. Key Executives Interviewed

Scope & coverage.

Types
  • Tirzepatide
  • Semaglutide
  • Liraglutide
  • Benaglutide
  • Others
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Novo Nordisk
  • Imeik
  • Borui Pharmaceuticals
  • Gan & Lee Pharmaceuticals
  • Hansoh Pharmaceuticals
  • Hengrui Medicine
  • Huadong Medicine
  • Eli Lilly
  • Shanghai Benemae Biopharmaceuticals Co., Ltd.
  • CSPC Pharmaceutical Group
  • Sihuan Pharmaceuticals
  • Wanbang Biopharma
  • Innovent Biologics

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global GLP-1 Weight Loss Injection Sales Value (2021-2032)
  4. 1.2.2 Global GLP-1 Weight Loss Injection Sales Volume (2021-2032)
  5. 1.2.3 Global GLP-1 Weight Loss Injection Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 GLP-1 Weight Loss Injection Market Dynamics
  1. 2.1 GLP-1 Weight Loss Injection Industry Trends
  2. 2.2 GLP-1 Weight Loss Injection Industry Drivers
  3. 2.3 GLP-1 Weight Loss Injection Industry Opportunities and Challenges
  4. 2.4 GLP-1 Weight Loss Injection Industry Restraints
3 GLP-1 Weight Loss Injection Market by Company
  1. 3.1 Global GLP-1 Weight Loss Injection Company Revenue Ranking in 2025
  2. 3.2 Global GLP-1 Weight Loss Injection Revenue by Company (2021-2026)
  3. 3.3 Global GLP-1 Weight Loss Injection Sales Volume by Company (2021-2026)
  4. 3.4 Global GLP-1 Weight Loss Injection Average Price by Company (2021-2026)
  5. 3.5 Global GLP-1 Weight Loss Injection Company Ranking (2024-2026)
  6. 3.6 Global GLP-1 Weight Loss Injection Company Manufacturing Base and Headquarters
  7. 3.7 Global GLP-1 Weight Loss Injection Company Product Type and Application
  8. 3.8 Global GLP-1 Weight Loss Injection Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global GLP-1 Weight Loss Injection Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 GLP-1 Weight Loss Injection Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 GLP-1 Weight Loss Injection Market by Type
  1. 4.1 GLP-1 Weight Loss Injection Type Introduction
  2. 4.1.1 Tirzepatide
  3. 4.1.2 Semaglutide
  4. 4.1.3 Liraglutide
  5. 4.1.4 Benaglutide
  6. 4.1.5 Others
  7. 4.2 Global GLP-1 Weight Loss Injection Sales Volume by Type
  8. 4.2.1 Global GLP-1 Weight Loss Injection Sales Volume by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global GLP-1 Weight Loss Injection Sales Volume by Type (2021-2032)
  10. 4.2.3 Global GLP-1 Weight Loss Injection Sales Volume Share by Type (2021-2032)
  11. 4.3 Global GLP-1 Weight Loss Injection Sales Value by Type
  12. 4.3.1 Global GLP-1 Weight Loss Injection Sales Value by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global GLP-1 Weight Loss Injection Sales Value by Type (2021-2032)
  14. 4.3.3 Global GLP-1 Weight Loss Injection Sales Value Share by Type (2021-2032)
5 GLP-1 Weight Loss Injection Market by Application
  1. 5.1 GLP-1 Weight Loss Injection Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Others
  5. 5.2 Global GLP-1 Weight Loss Injection Sales Volume by Application
  6. 5.2.1 Global GLP-1 Weight Loss Injection Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global GLP-1 Weight Loss Injection Sales Volume by Application (2021-2032)
  8. 5.2.3 Global GLP-1 Weight Loss Injection Sales Volume Share by Application (2021-2032)
  9. 5.3 Global GLP-1 Weight Loss Injection Sales Value by Application
  10. 5.3.1 Global GLP-1 Weight Loss Injection Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global GLP-1 Weight Loss Injection Sales Value by Application (2021-2032)
  12. 5.3.3 Global GLP-1 Weight Loss Injection Sales Value Share by Application (2021-2032)
6 GLP-1 Weight Loss Injection Regional Sales and Value Analysis
  1. 6.1 Global GLP-1 Weight Loss Injection Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global GLP-1 Weight Loss Injection Sales by Region (2021-2032)
  3. 6.2.1 Global GLP-1 Weight Loss Injection Sales by Region: 2021-2026
  4. 6.2.2 Global GLP-1 Weight Loss Injection Sales by Region (2027-2032)
  5. 6.3 Global GLP-1 Weight Loss Injection Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global GLP-1 Weight Loss Injection Sales Value by Region (2021-2032)
  7. 6.4.1 Global GLP-1 Weight Loss Injection Sales Value by Region: 2021-2026
  8. 6.4.2 Global GLP-1 Weight Loss Injection Sales Value by Region (2027-2032)
  9. 6.5 Global GLP-1 Weight Loss Injection Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America GLP-1 Weight Loss Injection Sales Value (2021-2032)
  12. 6.6.2 North America GLP-1 Weight Loss Injection Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe GLP-1 Weight Loss Injection Sales Value (2021-2032)
  15. 6.7.2 Europe GLP-1 Weight Loss Injection Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific GLP-1 Weight Loss Injection Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific GLP-1 Weight Loss Injection Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America GLP-1 Weight Loss Injection Sales Value (2021-2032)
  21. 6.9.2 South America GLP-1 Weight Loss Injection Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa GLP-1 Weight Loss Injection Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa GLP-1 Weight Loss Injection Sales Value Share by Country, 2025 VS 2032
7 GLP-1 Weight Loss Injection Country-level Sales and Value Analysis
  1. 7.1 Global GLP-1 Weight Loss Injection Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global GLP-1 Weight Loss Injection Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global GLP-1 Weight Loss Injection Sales by Country (2021-2032)
  4. 7.3.1 Global GLP-1 Weight Loss Injection Sales by Country (2021-2026)
  5. 7.3.2 Global GLP-1 Weight Loss Injection Sales by Country (2027-2032)
  6. 7.4 Global GLP-1 Weight Loss Injection Sales Value by Country (2021-2032)
  7. 7.4.1 Global GLP-1 Weight Loss Injection Sales Value by Country (2021-2026)
  8. 7.4.2 Global GLP-1 Weight Loss Injection Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA GLP-1 Weight Loss Injection Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA GLP-1 Weight Loss Injection Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA GLP-1 Weight Loss Injection Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada GLP-1 Weight Loss Injection Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada GLP-1 Weight Loss Injection Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada GLP-1 Weight Loss Injection Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico GLP-1 Weight Loss Injection Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico GLP-1 Weight Loss Injection Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico GLP-1 Weight Loss Injection Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany GLP-1 Weight Loss Injection Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany GLP-1 Weight Loss Injection Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany GLP-1 Weight Loss Injection Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France GLP-1 Weight Loss Injection Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France GLP-1 Weight Loss Injection Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France GLP-1 Weight Loss Injection Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. GLP-1 Weight Loss Injection Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. GLP-1 Weight Loss Injection Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. GLP-1 Weight Loss Injection Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy GLP-1 Weight Loss Injection Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy GLP-1 Weight Loss Injection Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy GLP-1 Weight Loss Injection Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain GLP-1 Weight Loss Injection Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain GLP-1 Weight Loss Injection Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain GLP-1 Weight Loss Injection Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia GLP-1 Weight Loss Injection Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia GLP-1 Weight Loss Injection Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia GLP-1 Weight Loss Injection Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands GLP-1 Weight Loss Injection Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands GLP-1 Weight Loss Injection Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands GLP-1 Weight Loss Injection Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries GLP-1 Weight Loss Injection Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries GLP-1 Weight Loss Injection Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries GLP-1 Weight Loss Injection Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China GLP-1 Weight Loss Injection Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China GLP-1 Weight Loss Injection Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China GLP-1 Weight Loss Injection Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan GLP-1 Weight Loss Injection Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan GLP-1 Weight Loss Injection Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan GLP-1 Weight Loss Injection Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea GLP-1 Weight Loss Injection Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea GLP-1 Weight Loss Injection Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea GLP-1 Weight Loss Injection Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India GLP-1 Weight Loss Injection Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India GLP-1 Weight Loss Injection Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India GLP-1 Weight Loss Injection Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia GLP-1 Weight Loss Injection Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia GLP-1 Weight Loss Injection Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia GLP-1 Weight Loss Injection Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia GLP-1 Weight Loss Injection Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia GLP-1 Weight Loss Injection Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia GLP-1 Weight Loss Injection Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil GLP-1 Weight Loss Injection Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil GLP-1 Weight Loss Injection Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil GLP-1 Weight Loss Injection Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina GLP-1 Weight Loss Injection Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina GLP-1 Weight Loss Injection Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina GLP-1 Weight Loss Injection Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile GLP-1 Weight Loss Injection Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile GLP-1 Weight Loss Injection Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile GLP-1 Weight Loss Injection Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia GLP-1 Weight Loss Injection Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia GLP-1 Weight Loss Injection Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia GLP-1 Weight Loss Injection Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru GLP-1 Weight Loss Injection Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru GLP-1 Weight Loss Injection Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru GLP-1 Weight Loss Injection Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia GLP-1 Weight Loss Injection Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia GLP-1 Weight Loss Injection Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia GLP-1 Weight Loss Injection Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel GLP-1 Weight Loss Injection Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel GLP-1 Weight Loss Injection Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel GLP-1 Weight Loss Injection Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE GLP-1 Weight Loss Injection Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE GLP-1 Weight Loss Injection Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE GLP-1 Weight Loss Injection Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey GLP-1 Weight Loss Injection Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey GLP-1 Weight Loss Injection Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey GLP-1 Weight Loss Injection Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran GLP-1 Weight Loss Injection Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran GLP-1 Weight Loss Injection Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran GLP-1 Weight Loss Injection Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt GLP-1 Weight Loss Injection Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt GLP-1 Weight Loss Injection Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt GLP-1 Weight Loss Injection Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Novo Nordisk
  2. 8.1.1 Novo Nordisk Company Information
  3. 8.1.2 Novo Nordisk Business Overview
  4. 8.1.3 Novo Nordisk GLP-1 Weight Loss Injection Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Novo Nordisk GLP-1 Weight Loss Injection Product Portfolio
  6. 8.1.5 Novo Nordisk Recent Developments
  7. 8.2 Imeik
  8. 8.2.1 Imeik Company Information
  9. 8.2.2 Imeik Business Overview
  10. 8.2.3 Imeik GLP-1 Weight Loss Injection Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Imeik GLP-1 Weight Loss Injection Product Portfolio
  12. 8.2.5 Imeik Recent Developments
  13. 8.3 Borui Pharmaceuticals
  14. 8.3.1 Borui Pharmaceuticals Company Information
  15. 8.3.2 Borui Pharmaceuticals Business Overview
  16. 8.3.3 Borui Pharmaceuticals GLP-1 Weight Loss Injection Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Borui Pharmaceuticals GLP-1 Weight Loss Injection Product Portfolio
  18. 8.3.5 Borui Pharmaceuticals Recent Developments
  19. 8.4 Gan & Lee Pharmaceuticals
  20. 8.4.1 Gan & Lee Pharmaceuticals Company Information
  21. 8.4.2 Gan & Lee Pharmaceuticals Business Overview
  22. 8.4.3 Gan & Lee Pharmaceuticals GLP-1 Weight Loss Injection Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Gan & Lee Pharmaceuticals GLP-1 Weight Loss Injection Product Portfolio
  24. 8.4.5 Gan & Lee Pharmaceuticals Recent Developments
  25. 8.5 Hansoh Pharmaceuticals
  26. 8.5.1 Hansoh Pharmaceuticals Company Information
  27. 8.5.2 Hansoh Pharmaceuticals Business Overview
  28. 8.5.3 Hansoh Pharmaceuticals GLP-1 Weight Loss Injection Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Hansoh Pharmaceuticals GLP-1 Weight Loss Injection Product Portfolio
  30. 8.5.5 Hansoh Pharmaceuticals Recent Developments
  31. 8.6 Hengrui Medicine
  32. 8.6.1 Hengrui Medicine Company Information
  33. 8.6.2 Hengrui Medicine Business Overview
  34. 8.6.3 Hengrui Medicine GLP-1 Weight Loss Injection Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Hengrui Medicine GLP-1 Weight Loss Injection Product Portfolio
  36. 8.6.5 Hengrui Medicine Recent Developments
  37. 8.7 Huadong Medicine
  38. 8.7.1 Huadong Medicine Company Information
  39. 8.7.2 Huadong Medicine Business Overview
  40. 8.7.3 Huadong Medicine GLP-1 Weight Loss Injection Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Huadong Medicine GLP-1 Weight Loss Injection Product Portfolio
  42. 8.7.5 Huadong Medicine Recent Developments
  43. 8.8 Eli Lilly
  44. 8.8.1 Eli Lilly Company Information
  45. 8.8.2 Eli Lilly Business Overview
  46. 8.8.3 Eli Lilly GLP-1 Weight Loss Injection Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Eli Lilly GLP-1 Weight Loss Injection Product Portfolio
  48. 8.8.5 Eli Lilly Recent Developments
  49. 8.9 Shanghai Benemae Biopharmaceuticals Co., Ltd.
  50. 8.9.1 Shanghai Benemae Biopharmaceuticals Co., Ltd. Company Information
  51. 8.9.2 Shanghai Benemae Biopharmaceuticals Co., Ltd. Business Overview
  52. 8.9.3 Shanghai Benemae Biopharmaceuticals Co., Ltd. GLP-1 Weight Loss Injection Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Shanghai Benemae Biopharmaceuticals Co., Ltd. GLP-1 Weight Loss Injection Product Portfolio
  54. 8.9.5 Shanghai Benemae Biopharmaceuticals Co., Ltd. Recent Developments
  55. 8.10 CSPC Pharmaceutical Group
  56. 8.10.1 CSPC Pharmaceutical Group Company Information
  57. 8.10.2 CSPC Pharmaceutical Group Business Overview
  58. 8.10.3 CSPC Pharmaceutical Group GLP-1 Weight Loss Injection Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 CSPC Pharmaceutical Group GLP-1 Weight Loss Injection Product Portfolio
  60. 8.10.5 CSPC Pharmaceutical Group Recent Developments
  61. 8.11 Sihuan Pharmaceuticals
  62. 8.11.1 Sihuan Pharmaceuticals Company Information
  63. 8.11.2 Sihuan Pharmaceuticals Business Overview
  64. 8.11.3 Sihuan Pharmaceuticals GLP-1 Weight Loss Injection Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Sihuan Pharmaceuticals GLP-1 Weight Loss Injection Product Portfolio
  66. 8.11.5 Sihuan Pharmaceuticals Recent Developments
  67. 8.12 Wanbang Biopharma
  68. 8.12.1 Wanbang Biopharma Company Information
  69. 8.12.2 Wanbang Biopharma Business Overview
  70. 8.12.3 Wanbang Biopharma GLP-1 Weight Loss Injection Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Wanbang Biopharma GLP-1 Weight Loss Injection Product Portfolio
  72. 8.12.5 Wanbang Biopharma Recent Developments
  73. 8.13 Innovent Biologics
  74. 8.13.1 Innovent Biologics Company Information
  75. 8.13.2 Innovent Biologics Business Overview
  76. 8.13.3 Innovent Biologics GLP-1 Weight Loss Injection Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Innovent Biologics GLP-1 Weight Loss Injection Product Portfolio
  78. 8.13.5 Innovent Biologics Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 GLP-1 Weight Loss Injection Value Chain Analysis
  2. 9.1.1 GLP-1 Weight Loss Injection Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 GLP-1 Weight Loss Injection Sales Mode & Process
  6. 9.2 GLP-1 Weight Loss Injection Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 GLP-1 Weight Loss Injection Distributors
  9. 9.2.3 GLP-1 Weight Loss Injection Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst